WO2012146574A1 - Semiconductor materials based on diketopiperidinopiperidine copolymers - Google Patents

Semiconductor materials based on diketopiperidinopiperidine copolymers Download PDF

Info

Publication number
WO2012146574A1
WO2012146574A1 PCT/EP2012/057438 EP2012057438W WO2012146574A1 WO 2012146574 A1 WO2012146574 A1 WO 2012146574A1 EP 2012057438 W EP2012057438 W EP 2012057438W WO 2012146574 A1 WO2012146574 A1 WO 2012146574A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
cor
monovalent
independently
substituents
Prior art date
Application number
PCT/EP2012/057438
Other languages
French (fr)
Inventor
Ashok Kumar Mishra
Subramanian Vaidyanathan
Hiroyoshi Noguchi
Florian DÖTZ
Yucui GUAN
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Priority to EP12716040.6A priority Critical patent/EP2702086B1/en
Priority to JP2014506832A priority patent/JP5777802B2/en
Priority to KR1020137031153A priority patent/KR101486694B1/en
Priority to CN201280020623.4A priority patent/CN103492452B/en
Publication of WO2012146574A1 publication Critical patent/WO2012146574A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G61/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G61/12Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G61/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G61/12Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
    • C08G61/122Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule derived from five- or six-membered heterocyclic compounds, other than imides
    • C08G61/123Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule derived from five- or six-membered heterocyclic compounds, other than imides derived from five-membered heterocyclic compounds
    • C08G61/126Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule derived from five- or six-membered heterocyclic compounds, other than imides derived from five-membered heterocyclic compounds with a five-membered ring containing one sulfur atom in the ring
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L65/00Compositions of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain; Compositions of derivatives of such polymers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00Other synthetic dyes of known constitution
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B69/00Dyes not provided for by a single group of this subclass
    • C09B69/10Polymeric dyes; Reaction products of dyes with monomers or with macromolecular compounds
    • C09B69/109Polymeric dyes; Reaction products of dyes with monomers or with macromolecular compounds containing other specific dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K99/00Subject matter not provided for in other groups of this subclass
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/10Definition of the polymer structure
    • C08G2261/12Copolymers
    • C08G2261/124Copolymers alternating
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/10Definition of the polymer structure
    • C08G2261/14Side-groups
    • C08G2261/141Side-chains having aliphatic units
    • C08G2261/1412Saturated aliphatic units
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/30Monomer units or repeat units incorporating structural elements in the main chain
    • C08G2261/32Monomer units or repeat units incorporating structural elements in the main chain incorporating heteroaromatic structural elements in the main chain
    • C08G2261/322Monomer units or repeat units incorporating structural elements in the main chain incorporating heteroaromatic structural elements in the main chain non-condensed
    • C08G2261/3223Monomer units or repeat units incorporating structural elements in the main chain incorporating heteroaromatic structural elements in the main chain non-condensed containing one or more sulfur atoms as the only heteroatom, e.g. thiophene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/30Monomer units or repeat units incorporating structural elements in the main chain
    • C08G2261/32Monomer units or repeat units incorporating structural elements in the main chain incorporating heteroaromatic structural elements in the main chain
    • C08G2261/324Monomer units or repeat units incorporating structural elements in the main chain incorporating heteroaromatic structural elements in the main chain condensed
    • C08G2261/3243Monomer units or repeat units incorporating structural elements in the main chain incorporating heteroaromatic structural elements in the main chain condensed containing one or more sulfur atoms as the only heteroatom, e.g. benzothiophene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/30Monomer units or repeat units incorporating structural elements in the main chain
    • C08G2261/34Monomer units or repeat units incorporating structural elements in the main chain incorporating partially-aromatic structural elements in the main chain
    • C08G2261/344Monomer units or repeat units incorporating structural elements in the main chain incorporating partially-aromatic structural elements in the main chain containing heteroatoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/40Polymerisation processes
    • C08G2261/41Organometallic coupling reactions
    • C08G2261/414Stille reactions
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/90Applications
    • C08G2261/91Photovoltaic applications
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/90Applications
    • C08G2261/92TFT applications
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K10/00Organic devices specially adapted for rectifying, amplifying, oscillating or switching; Organic capacitors or resistors having potential barriers
    • H10K10/40Organic transistors
    • H10K10/46Field-effect transistors, e.g. organic thin-film transistors [OTFT]
    • H10K10/462Insulated gate field-effect transistors [IGFETs]
    • H10K10/484Insulated gate field-effect transistors [IGFETs] characterised by the channel regions

Definitions

  • Organic semiconducting materials can be used in electronic devices such as organic photo- voltaic devices (OPVs), organic field-effect transistors (OFETs), organic light emitting diodes (OLEDs), and organic electrochromic devices (ECDs).
  • OCVs organic photo- voltaic devices
  • OFETs organic field-effect transistors
  • OLEDs organic light emitting diodes
  • ECDs organic electrochromic devices
  • the organic semiconducting material-based devices show high charge carrier mobility as well as high stability, in particular to- wards oxidation by air, under ambient environmental conditions.
  • the organic semiconducting materials are compatible with liquid processing techniques such as spin coating as liquid processing techniques are convenient from the point of processability, and thus allow the production of low cost organic semiconduct- ing material-based electronic devices.
  • liquid processing techniques are also compatible with plastic substrates, and thus allow the production of light weight and mechanically flexible organic semiconducting material-based electronic devices.
  • Bao, Z.; Dobadalapur, A.; Lovinger, A. J. Appl. Phys. Lett. 1996, 69, 4108-41 10 describes the use of regioregular poly(3-hexylthiophene) in field-effect transistors.
  • OFETs organic field effect transistors
  • OFETs organic field effect transistors
  • Diketopiperidinopiperidine derivatives are also known in the art.
  • Ar C 6 H 5 , 2-MeC 6 H 4 , 2,4,6-Me '3,C R 6H' ',2
  • the semiconducting material of the present invention is a polymer comprising a unit of formula
  • R 1 and R 2 are independently from each other H, Ci-30-alkyl optionally substituted with 1 to 6 substituents R c , C2-3o-alkenyl optionally substituted with 1 to 6 substituents R c , C2-3o-alkynyl optionally substituted with 1 to 6 substituents R c , C3-io-cycloalkyl optionally substituted with 1 to 6 substituents R d , Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents R d , monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R d , C6-i4-aryl optionally substituted with 1 to 6 substituents R e or monovalent 5 to14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R e , wherein
  • G 1 and G 2 are independently from each other -i4-arylene optionally substituted with 1 to 6 substituents R a or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R a , wherein
  • R 8 and R 9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C 2- 3o-alkenyl, C 2- 3o-alkynyl, -io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
  • G 1 and G 2 are independently from each other
  • R 5 and R 6 are independently from each other H or Ci
  • R 12 and R 13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C 2- 3o-alkenyl, C 2- 3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
  • R 16 and R 17 are independently from each other H , Ci-30-alkyl, -CN or halogen,
  • q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10 ⁇ 00.
  • the semiconducting material of the present invention is a polymer consisting essentially of a unit of formula wherein R 1 and R 2 are independently from each other H , Ci-30-alkyl optionally substituted with 1 to 6 substituents R c , C2-3o-alkenyl optionally substituted with 1 to 6 substituents R c , C2-3o-alkynyl optionally substituted with 1 to 6 substituents R c , C3-io-cycloalkyl optionally substituted with 1 to 6 substituents R d , Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents R d , monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R d , C6-i4-aryl optionally substituted with 1 to 6 substituents R e or monovalent 5 to14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R e
  • G 1 and G 2 are independently from each other C6-i4-arylene optionally substituted with 1 to 6 substituents R a or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R a , wherein
  • R 10 and R 11 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C 2- io-alkenyl, C 2- io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic hetero- cyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, or
  • G 1 and G 2 are independently from each other
  • R 5 and R 6 are independently from each other H or Ci-30-alkyl
  • L is C6-24-arylene optionally substituted with 1 to 6 substituents R b or bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R b , wherein
  • R 12 and R 13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C 2- 3o-alkenyl, C 2- 3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
  • R 16 and R 17 are independently from each other H, Ci-30-alkyl, -CN or halogen,
  • q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10 ⁇ 00.
  • the term "consisting essentially of” means that at least 80% by weight. Preferably at least 90% by weight, of the polymer consists of a unit of formula (1 ) based on the weight of the polymer.
  • the semiconducting material of the present invention is a polymer of formula wherein R 1 and R 2 are independently from each other H , Ci-30-alkyl optionally substituted with 1 to 6 substituents R c , C2-3o-alkenyl optionally substituted with 1 to 6 substituents R c , C2-3o-alkynyl optionally substituted with 1 to 6 substituents R c , C3-io-cycloalkyl optionally substituted with 1 to 6 substituents R d , Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents R d , monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R d , C6-i4-aryl optionally substituted with 1 to 6 substituents R e or monovalent 5 to14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R e , wherein
  • G 1 and G 2 are independently from each other -i4-arylene optionally substituted with 1 to 6 substituents R a or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R a , wherein
  • G 1 and G 2 are independently from each other
  • R 5 and R 6 are independently from each other H or Ci-30-alkyl
  • L is C6-24-arylene optionally substituted with 1 to 6 substituents R b or bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R b , wherein
  • R 12 and R 13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C 2- 3o-alkenyl, C 2- 3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
  • R 16 and R 17 are independently from each other H, Ci-30-alkyl, -CN or halogen,
  • q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10 ⁇ 00.
  • Ci-12-alkyl, Ci-16-alkyl, C6- 2 o-alkyl and Ci-30-alkyl can be branched or unbranched.
  • Examples of Ci-12-alkyl are Ci-10-alkyl and n-undecyl and n-dodecyl.
  • Examples of Ci-16-alkyl are Ci-i 2 -alkyl and n-tridecyl, n-tetradecyl, n-pentadecyl and n-hexadecyl.
  • Ci-30-alkyl are examples of Ci-12-alkyl, Ci-16-alkyl, C6- 2 o-alkyl and Ci-30-alkyl.
  • Ci-io-alkyl and n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C 20 ), n-docosyl (C 22 ), n-tetracosyl (C 24 ), n-hexacosyl (C 2 6) , n-octacosyl (C 2 s) and n-triacontyl (C30).
  • C6- 2 o-alkyl examples include n-hexyl, n-heptyl, n-octyl, n-(2-ethyl)hexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20)
  • C2-io-alkenyl and C2-3o-alkenyl can be branched or unbranched.
  • C2-io-alkenyl examples include vinyl, propenyl, c/s-2-butenyl, frans-2-butenyl, 3-butenyl, c/s-2-pentenyl, frans-2-pentenyl, c/s-3-pentenyl, frans-3-pentenyl, 4-pentenyl, 2-methyl-3-butenyl, hexenyl, heptenyl, octenyl, nonenyl and docenyl.
  • C2-3o-alkenyl examples include C2-io-alkenyl, and linoleyl (ds), linolenyl (Cis), oleyl (Cis), arachidonyl (C20), and erucyl (C22).
  • C2-io-alkynyl and C2-3o-alkynyl can be branched or unbranched.
  • Examples of C2-io-alkynyl are ethynyl, 2-propynyl, 2-butynyl, 3-butynyl, pentynyl, hexynyl, heptynyl, octynyl, nonynyl and de- cynyl.
  • C2-3o-alkynyl examples include C2-io-alkynyl, and undecynyl, dodecynyl, undecynyl, dode- cynyl, tridecynyl, tetradecynyl, pentadecynyl, hexadecynyl, heptadecynyl, octadecynyl, nonade- cynyl and icosynyl (C20).
  • C3-io-cycloalkyl are preferably monocyclic C3-io-cycloalkyls such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl, but include also polycyclic C3-io-cycloalkyls such as decalinyl, norbornyl and adamantyl.
  • Cs-io-cycloalkenyl are preferably monocyclic Cs-io-cycloalkenyls such as cyclopen- tenyl, cyclohexenyl, cyclohexadienyl and cycloheptatrienyl, but include also polycyclic
  • Cs-io-cycloalkenyls examples include monovalent 3 to 14 membered aliphatic heterocyclic residues.
  • monovalent 3 to 14 membered aliphatic heterocyclic residues are monocyclic monovalent 3 to 8 membered aliphatic cyclic residues and polycyclic, for example bicyclic monovalent 7 to 12 membered aliphatic heterocyclic residues.
  • Examples of monocyclic monovalent 3 to 8 membered aliphatic heterocyclic residues are mon- ocyclic monovalent 5 membered aliphatic heterocyclic residues containing one heteroatom such as pyrrolidinyl, 1 -pyrrolinyl, 2-pyrrolinyl, 3-pyrrolinyl, tetrahydrofuryl, 2,3-dihydrofuryl, tetrahy- drothiophenyl and 2,3-dihydrothiophenyl, monocyclic monovalent 5 membered aliphatic heterocyclic residues containing two heteroatoms such as imidazolidinyl, imidazolinyl, pyrazolidinyl, pyrazolinyl, oxazolidinyl, oxazolinyl, isoxazolidinyl, isoxazolinyl, thiazolidinyl, thiazolinyl, isothia- zolidinyl and is
  • bicyclic monovalent 7-12 membered aliphatic heterocyclic residue is decahy- dronaphthyl.
  • C6-i4-aryl can be monocyclic or polycyclic.
  • Examples of C6-i4-aryl are monocyclic C6-aryl such as phenyl, bicyclic Cg-io-aryl such as 1 -naphthyl, 2-naphthyl, indenyl, indanyl and tetrahy- dronaphthyl, and tricyclic Ci2-i4-aryl such as anthryl, phenanthryl, fluorenyl and s-indacenyl.
  • the monovalent 5 to 14 membered aromatic heterocyclic residues can be monocyclic monovalent 5 to 8 membered aromatic heterocyclic residues, or polycyclic, for example bicyclic mono- valent 7 to 12 membered, tricyclic monovalent 9 to 14 membered aromatic heterocyclic residue, or tetracyclic monovalent 9 to 14 membered aromatic heterocyclic residues.
  • Examples of monocyclic monovalent 5 to 8 membered aromatic heterocyclic residues are mon- ocyclic monovalent 5 membered aromatic heterocyclic residues containing one heteroatom such as pyrrolyl, furyl and thiophenyl, monocyclic monovalent 5 membered aromatic heterocyclic residues containing two heteroatoms such as imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thia- zolyl, isothiazolyl, monocyclic monovalent 5 membered aromatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazolyl, 1 ,2,4-triazolyl and oxadiazolyl, monocyclic mono- valent 5 membered aromatic heterocyclic residues containing four heteroatoms such as tetra- zolyl, monocyclic monovalent 6 membered aromatic heterocyclic residues containing one heteroatom such as pyridyl, monocyclic monovalent 6 membered aromatic hetero
  • bicyclic monovalent 7 to 12 membered aromatic heterocyclic residues are bicyclic monovalent 8 membered aromatic heterocyclic residues containing two heteroatoms such as thieno[3,2-b]thiophenyl, bicyclic 9 membered aromatic heterocyclic residues containing one heteroatom such as indolyl, isoindolyl, indolizinyl, indolinyl, benzofuryl, isobenzofuryl, ben- zothiophenyl and isobenzothiophenyl, bicyclic monovalent 9 membered aromatic heterocyclic residues containing two heteroatoms such as indazolyl, benzimidazolyl, benzimidazolinyl, ben- zoxazolyl, benzisooxazolyl, benzthiazolyl, benzisothiazolyl, furopyridyl and thienopyridyl, bicyclic monovalent 9 membered aromatic heterocyclic
  • tricyclic monovalent 9 to 14 membered aromatic heterocyclic residues examples include dibenzo- furyl, acridinyl, phenoxazinyl, 7H-cyclopenta[1 ,2-b:3,4-b']dithiophenyl and 4H-cyclopenta- [2,1 -b:3,4-b']dithiophenyl.
  • An example of a tricyclic monovalent 9 to 14 membered aromatic heterocyclic residue containing three heteroatoms is dithienothiophenyl of formula
  • halogen examples are -F, -CI, -Br and -I.
  • Ci-10-alkoxy examples are methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, fert-butoxy, n-pentoxy, neopentoxy, isopentoxy, hexoxy, n-heptoxy, n-octoxy, n-nonoxy and n-decoxy.
  • Ci-30-alkoxy are Ci-10-alkoxy, and n-undecoxy,
  • n-dodecoxy n-undecoxy, n-dodecoxy, n-tridecoxy, n-tetradecoxy, n-pentadecoxy, n-hexa- decoxy, n-heptadecoxy, n-octadecoxy, n-nonadecoxy and n-icosoxy (C20), n-docosoxy (C22), n-tetracosoxy (C24), n-hexacosoxy (C26), n-octacosoxy (C28) and n-triacontoxy (C30).
  • C2-6-alkylene examples include ethylene, butylene, pentylene, hexylene and 2-methylpentylene.
  • C6-i4-arylene examples include monocyclic C6-arylene such as phenylene, bicyclic Cg-io-arylene such as naphthylene, for example
  • Ci2-i4-arylene such as anthrylene, for example
  • phenanthrylene for example fluorenylene
  • C6-24-arylene examples include C6-i4-arylene and pyrenylene, for example
  • the bivalent 5 to 14 membered aromatic heterocyclic residues can be monocyclic bivalent 5 to 8 membered aromatic heterocyclic residues, or polycyclic, for example bicyclic bivalent 7 to 14 membered, tricyclic bivalent 9 to 14 membered aromatic heterocyclic residues, or tetracyclic bivalent 9 to 14 membered aromatic heterocyclic residues.
  • monocyclic bivalent 5 to 8 membered aromatic heterocyclic residues are monocyclic bivalent 5 membered aromatic heterocyclic residues containing one heteroatom such as pyr- rolylene, furylene and thiophenylene, monocyclic bivalent 5 membered aromatic heterocyclic residues containing two heteroatoms such as imidazolylene, pyrazolylene, oxazolylene, isoxa- zolylene, thiazolylene, isothiazolylene, monocyclic bivalent 5 membered aromatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazolylene, 1 ,2,4-triazolylene and oxadia- zolylene, monocyclic bivalent 5 membered aromatic heterocyclic residues containing four heteroatoms such as tetrazolylene, monocyclic bivalent 6 membered aromatic heterocyclic residues containing one heteroatom such as pyridylene, monocyclic bivalent 6 membered aromatic heterocyclic residues
  • bicyclic bivalent 7 to 14 membered aromatic heterocyclic residues are examples of bicyclic bivalent 7 to 14 membered aromatic heterocyclic residues.
  • bicyclic bivalent 8 membered aromatic heterocyclic residues containing three heteroatoms such as as thienothiazolylene for example bicyclic bivalent 8 membered aromatic heterocyclic residues containing four heteroatoms such as thiazothiazolylene, for example bicyclic bivalent 9 membered aromatic heterocyclic residues containing one heteroatom such as indolylene, isoindolylene, indolizinylene, indolinylene, isoindolinylene, for example
  • bicyclic bivalent 9 membered aromatic heterocyclic residues containing four heteroatoms such as purinylene
  • bicyclic bivalent 10 membered aromatic heterocyclic residues containing one heteroatom such as quinolylene, isoquinolylene, chromenylene and chromanylene
  • bicyclic bivalent 10 membered aromatic heterocyclic residues containing two heteroatoms such as quinoxalinylene
  • quinazolinylene cinnolinylene, phthalazinylene, 1 ,5-naphthyridinylene and
  • bicyclic bivalent 10 membered aromatic heterocyclic residues containing three heteroatoms such as pyridopyrazinylene, pyridopyrimidinylene and pyridopyridazinylene
  • bicyclic bivalent 10 membered aromatic heterocyclic residues containing four heteroatoms such as pterid- inylene.
  • tricyclic bivalent 9 to 14 membered aromatic heterocyclic residues containing one heteroatom are dibenzofurylene, acridinylene, dibenzosilacyclopentadienylene, for example
  • Examples of a tricyclic bivalent 9 to 14 membered aromatic heterocyclic residues containing two heteroatoms are phenoxazinylene, and the following compounds
  • tricyclic bivalent 9 to 14 membered aromatic heterocyclic residue containing three heteroatoms are the following compounds
  • tricyclic bivalent 9 to 14 membered aromatic heterocyclic residue containing four- heteroatoms are the following compounds
  • bivalent 5 to 24 membered aromatic heterocyclic residues are bivalent 5 to 14 membered aromatic heterocyclic residues, and the following compounds
  • Examples of L are:
  • G 1 and G 2 are independently from each other -i4-arylene optionally substituted with 1 to 6 substituents R a or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R a , wherein
  • R 8 and R 9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C 2- 3o-alkenyl, C 2- 3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
  • G 1 and G 2 are independently from each other
  • R 5 and R 6 are independently from each other H or Ci
  • L is C6-24-arylene optionally substituted with 1 to 6 substituents R b or bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R b , wherein
  • R 12 and R 13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue
  • R 16 and R 17 are independently from each other H, Ci-30-alkyl, -CN or halogen,
  • q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10 ⁇ 00.
  • r is 0, 1 or 2
  • n is an integer from 2 to 10 ⁇ 00.
  • R 1 and R 2 are independently from each other Ci-30-alkyl optionally substituted with 1 to 6 substituents R c , preferably Ci -alkyl optionally substituted with 1 to 6 substituents R c , more preferably Ci-12-alkyl optionally substituted with 1 to 6 substituents R c , wherein
  • G 1 and G 2 are independently from each other -i4-arylene optionally substituted with 1 to 6 substituents R a or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R a , wherein
  • R 8 and R 9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C 2- 3o-alkenyl, C 2- 3o-alkynyl, -io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue
  • G 1 and G 2 are independently from each other
  • R 5 and R 6 are independently from each other H or Ci-30-alkyl
  • L is C6- 2 4-arylene optionally substituted with 1 to 6 substituents R b or bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R b , wherein
  • R 12 and R 13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
  • R 16 and R 17 are independently from each other H, Ci-30-alkyl, -CN or halogen, q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10 ⁇ 00.
  • R 1 and R 2 are independently from each other Ci-30-alkyl optionally substituted with 1 to 6 sub- stituents R c , preferably Ci-16-alkyl optionally substituted with 1 to 6 substituents R c , more preferably Ci-12-alkyl optionally substituted with 1 to 6 substituents R c , wherein
  • G 1 and G 2 are independently from each other bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R a , wherein
  • R 8 and R 9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cyclo- alkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue
  • G 1 and G 2 are independently from each other
  • R 5 and R 6 are independently from each other H or Ci-30-alkyl, L is bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents R b , wherein
  • R 12 and R 13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C 2- 3o-alkenyl, C 2- 3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
  • R 16 and R 17 are independently from each other H, Ci-30-alkyl, -CN or halogen,
  • q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10 ⁇ 00.
  • R 1 and R 2 are independently from each other Ci-16-alkyl, more preferably Ci-12-alkyl,
  • G 1 and G 2 are independently from each other monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue optionally substituted with 1 to 4 substituents R a , wherein
  • R a at each occurrence are independently from each other Ci-30-alkyl optionally substituted with 1 to 4 substituents R f , wherein
  • L is bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 4 substituents R b , wherein
  • R b at each occurrence are independently from each other Ci-30-alkyl optionally substituted with 1 to 4 substituents R h , wherein
  • q and s are independently from each other 1 , 2 or 3, r is 1 or 2, and n is an integer from 5 to 10 ⁇ 00.
  • R 1 and R 2 are independently from each other Ci-16-alkyl, more preferably Ci-i 2 -alkyl, G 1 and G 2 are independently from each other monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue, wherein G 1 and G 2 are substituted with 1 to 2 substituents R a , wherein
  • R a at each occurrence are independently from each other C6- 2 o-alkyl
  • L is bivalent 5 to 14 membered aromatic heterocyclic residue, wherein L is substituted with 1 to 2 substituents R b , wherein
  • R b at each occurrence are independently from each other C6- 2 o-alkyl, q and s are both 1 , r is 1 , and n is an integer from 5 to 10 ⁇ 00.
  • Particular preferred units of formula (1 ) are units of formula
  • R 1 , R 2 , R a , L and n are as defined above.
  • R b is as defined above.
  • n is an integer from 5 to 5 ⁇ 00, more preferably from 5 to 1 ⁇ 00, even more preferably from 5 to 100, and most preferably from 10 to 100.
  • a particular preferred example of the units of formulae (1 ) and (1a) is the unit of formula
  • the semiconducting material of the present invention can be a polymer comprising preferably at least 80% by weight, more preferably at least 90% by weight, of a unit of formula (1 ), respectively, (1a) based on the weight of the polymer.
  • the semiconducting material of the present invention is a polymer consisting essentially of a unit of formula (1 ), respectively, (1a).
  • the polymer comprising a unit of formula (1 ) can be prepared by treating a compound of formula
  • R 1 , R 2 , G 1 , G 2 , q and s are as defined above, and Hal 1 is halogen, preferably -Br, with a compound of formula
  • L and q are as defined above, and R 100 , R 101 and R 102 are independently from each other Ci-io-alkyl, preferably methyl. in the presence of transition metal catalyst 1 .
  • Transition metal catalyst 1 is preferably a palladium catalyst such tris(dibenzylideneacetone)- dipalladium(O), preferably in combination with a phosphine such as tri-otolylphosphine.
  • the reaction is preferably performed at elevated temperatures such 80 to 200 °C, preferably 90 to 150 °C.
  • the reaction can be performed in an inert organic solvent such as chlorobenzene.
  • the reaction can be stopped by the addition of end cappers such as 2-bromothiophene and 2-thiophene boronic acid.
  • the crude product may be worked up by conventional methods, for example by extracting the crude product with an appropriate solvent, for example with acetone.
  • the compound of formula (2) can be prepared by treating a compound of formula
  • R 1 , R 2 , G 1 , G 2 , q and s are as defined above, with a halogenating agent.
  • the halogenating agent is preferably /V-bromosuccinimide.
  • the reaction is preferably performed at ambient temperatures such -5 to 50 °C, preferably 0 to 30 °C.
  • the reaction can be performed in an organic solvent such chloroform.
  • the crude product may be worked up by conventional methods, for example by column chromatography.
  • the compound of formula (4) can be prepared by reacting a compound of formula
  • G 1 , G 2 , q and s are as defined above, and R 200 , R 201 and R 202 are independently from each other Ci-10-alkyl, preferably methyl in the presence of a transition metal catalyst 2.
  • Transition metal catalyst 2 is preferably a palladium catalyst such tetrakis(triphenylphosphine) palladium(O).
  • the reaction is preferably performed at elevated temperatures such 80 to 200 °C, preferably 90 to 150 °C.
  • the reaction can be performed in an inert organic solvent such as di- methylformamide.
  • the crude product may be worked up by conventional methods, for example by column chromatography.
  • the compound of formula (5) can be prepared by treating a compound of formula
  • R 1 and R 2 are as defined above, with a halogenating agent.
  • the halogenating agent is preferably Br2.
  • the reaction is preferably performed at ambient temperatures such -5 to 30 °C, preferably 0 to 30 °C.
  • the reaction can be performed in an organic solvent such dichloromethane.
  • the crude product may be worked up by conventional methods.
  • the compound of formula (8) can be prepared according to following reaction scheme:
  • an electronic device comprising the polymer comprising a unit of formula (1 ) as semiconducting material.
  • the electronic device is an organic field effect transistor (OFET), and in particular a thin film transistor (TFT).
  • the elec- tronic device is an organic photovoltaic device (OPV).
  • an organic field effect transistor comprises a dielectric layer, a semiconducting layer and a substrate.
  • organic field effect transistor usually comprises a gate electrode and source/drain electrodes.
  • An organic field effect transistor can have various designs.
  • BGTC Bottom-Gate Top-Contact
  • the semiconducting layer comprises the semiconducting material of the present invention.
  • the semiconducting layer can have a thickness of 5 to 500 nm, preferably of 10 to 100 nm, more preferably of 20 to 50 nm.
  • the dielectric layer comprises a dielectric material.
  • the dielectric material can be silici- um/silicium dioxide, or, preferably, an organic polymer such as polystyrene (PS), polymethylmethacrylate) (PMMA), poly(4-vinylphenol) (PVP), polyvinyl alcohol) (PVA), anzocyclobutene (BCB), or polyimide (PI).
  • PS polystyrene
  • PMMA polymethylmethacrylate
  • PVP poly(4-vinylphenol)
  • PVA polyvinyl alcohol
  • BCB anzocyclobutene
  • PI polyimide
  • the dielectric layer can have a thickness of 10 to 2000 nm, preferably of 50 to 1000 nm, more preferably of 100 to 800 nm.
  • the source/drain contacts and the gate contact can be made from any suitable material, for example Au.
  • the substrate can be any suitable substrate such as glass, or a plastic substrate.
  • the substrate is a plastic substrate such as polyethersulfone, polycarbonate, polysulfone, polyethylene terephthalate (PET) and polyethylene naphthalate (PEN). More preferably, the plastic substrate is a plastic foil.
  • the organic field effect transistor can be prepared by methods known in the art.
  • a top-gate bottom-contact (TGBC) thin film transistors can be prepared as follows: first: the source/drain contacts are placed on the substrate, for example by thermal evaporation of the source/drain material; second: the substrate is coated with the semiconduct- ing layer, for example by spin-coating a solution of the semiconducting material in a suitable solvent and drying the semiconducting layer at elevated temperatures, for example at 80 to 100 °C; third: the semiconducting layer is coated with a solution of the dielectric material in a suitable solvent, for example by spin-coating a solution of the dielectric material and drying the dielectric layer at elevated temperatures, for example at 80 to 100 °C; fourth: the gate contact is placed on top of the dielectric layer, for example by thermal evaporation of the gate material.
  • TGBC top-gate bottom-contact
  • Also part of the present invention is the use of the polymer comprising the unit of formula (1 ) as semiconducting material.
  • Electronic devices comprising the semiconducting materials of the present invention show high charge carrier mobility as well as high stability, in particular towards oxidation by air, under ambient environmental conditions.
  • the semiconducting materials of the present invention are compatible with liquid processing techniques such as spin coating and thus allow the production of low cost, light weight and flexible electronic devices.
  • Methyl iodide (10.9 g, 76.8 mmol) is added to a solution of 1 ,5-naphthyridine (12) (5 g, 38.4 mmol) in MeOH (30 mL) and the reaction mixture is heated at 40 °C over 3 days under N2. The precipitate is filtered and dried under high vacuum to afford compound 1 1a as yellowish green solid (8.51 g, 81 .1 %).
  • 1 H NMR 400 MHz, CDCI 3 , r.t) ⁇ 9.49 (d, 1 H), 9.38 (dd, 1 H), 9.26 (d, 1 H), 8.98 (dd, 1 H), 4.75 (s, 3H).
  • Pd(PPh 3 )4 (0.1 1 g, 0.10 mmol) is added to a solution of compound 5a (0.68 g, 1.97 mmol) and compounds 6a (2.45 g, 5.90 mmol) in degassed dimethylformamide (23 ml_).
  • the reaction mixture is heated to 130 °C and stirred overnight.
  • the reaction mixture is allowed to cool to RT, washed with H2O (25 ml_), extracted with CH2CI2 (25 ml. x 3), dried over Na2S0 4 and concentrated.
  • the residue is purified by flash column (0 ⁇ 100% ethyl acetate/hexane) to afford com- pound 4a as red solid (0.42 g, 31 %).
  • top-gate bottom-contact transistors containing the polymer P1 , essentially consisting of the units of formula 1 b, as semiconducting material
  • a top-gate bottom-contact (TGBC) thin film transistor TFT is fabricated on glass (PGO glass used as received).
  • Au source-drain contacts (30 nm-thick) are thermally-evaporated.
  • the substrate is then coated with the semiconductor layer (thickness: 40 to 50 nm) by spin-coating (1000 rpm) a solution of polymer P1 (prepared as described in example 1 ) in dichloromethane (concentration ⁇ 10 mg/mL), and drying the film at 90 °C for 30 seconds.
  • a 4 weight% polysty- rene solution in isopropyl acetate is spin-coated (3600 rpm) and the dielectric film formed is dried at 90 °C for 30 seconds to yield a dielectric layer (thickness: 500 to 600 nm).
  • the top-gate, bottom-contact (TGBC) thin film transistors of example 2 show the following mobility: 4 x 10- 3 cm 2 V- 1 s- 1 .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Thin Film Transistor (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Photovoltaic Devices (AREA)

Abstract

The present invention provides a polymer comprising a unit of formula (1) and an electronic device comprising the polymer as semiconducting material.

Description

Semiconductor materials based on diketopiperidinopiperidine copolymers Description
Organic semiconducting materials can be used in electronic devices such as organic photo- voltaic devices (OPVs), organic field-effect transistors (OFETs), organic light emitting diodes (OLEDs), and organic electrochromic devices (ECDs).
For efficient and long lasting performance, it is desirable that the organic semiconducting material-based devices show high charge carrier mobility as well as high stability, in particular to- wards oxidation by air, under ambient environmental conditions.
Furthermore, it is desirable that the organic semiconducting materials are compatible with liquid processing techniques such as spin coating as liquid processing techniques are convenient from the point of processability, and thus allow the production of low cost organic semiconduct- ing material-based electronic devices. In addition, liquid processing techniques are also compatible with plastic substrates, and thus allow the production of light weight and mechanically flexible organic semiconducting material-based electronic devices.
The use of organic semiconducting materials is known in the art.
Bao, Z.; Dobadalapur, A.; Lovinger, A. J. Appl. Phys. Lett. 1996, 69, 4108-41 10 describes the use of regioregular poly(3-hexylthiophene) in field-effect transistors.
Ong, B. S.; Wu,Y.; Liu, P.; Gardner, S. J. Am. Chem. Soc. 2004, 126, 3378-3379 describes polymers of formula
Figure imgf000002_0001
for use in organic field effect transistors (OFETs).
Zhang, M.; Tsao, H. N.; Pisula, W.; Yang, C; Mishra, A. K.; Mullen, K. J. Am. Chem. Soc. 2007, 129, 3472-3473 describes polymers of formula
Figure imgf000002_0002
for use in organic field effect transistors (OFETs). Zou, Y.; Najari, A.; Berrouard, P.; Beaupre, S.; Badrou, R. A.; Tao, Y.; Leclerc, M. J. Am. Chem. Soc. 2010, 132, 5330-5331 describes polymers of formula
Figure imgf000003_0001
as donor materials for use in photovoltaic devices.
L. Burgi, M. Turbiez, R. Pfeiffer, F. Bienewald, H.-J. Kirner, C. Winnewisser, Adv. Mater. 2008, 20, 2217-2224 describes polymers of formula
Figure imgf000003_0002
for use in organic field effect transistors (OFETs).
J. C. Bijleveld, A. P. Zoombelt, S. G. J. Mathijssen, M. M. Wienk, M. Turbiez, D. M. de Leeuw, R. A. J. Janssen, J. Am. Chem. Soc. 2009, 131 , 16616-16617 describes polymers of formula
Figure imgf000003_0003
for use in organic field effect transistors (OFETs) and organic photovoltaic devices (OPVs). N. Saito, T. Yamamoto Macromolecules 1995, 28, 4260-4267 describes polymers of formula
Figure imgf000004_0001
as an electrical conductor.
Diketopiperidinopiperidine derivatives are also known in the art.
E. Bisagni, C. Landras, S. Thirot, C. Huel. Tetrahedron, 1996, 52 (31 ), 10427-10440 describes the synthesis of compound of formula
Figure imgf000004_0002
H. Irikawa, N. Adachi Heterocycles 2000, 53 (1 ), 135-142 describes the synthesis of compound of formula
Figure imgf000004_0003
X = NMe, O
Ar = C6H5, 2-MeC6H4, 2,4,6-Me '3,CR6H' ',2
It was the object of the present invention to provide new organic semiconducting materials. This object is solved by the polymer of claim 1 and the electronic device of claim 17. The semiconducting material of the present invention is a polymer comprising a unit of formula
Figure imgf000005_0001
wherein
R1 and R2 are independently from each other H, Ci-30-alkyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rc, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rd, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rd, monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rd, C6-i4-aryl optionally substituted with 1 to 6 substituents Re or monovalent 5 to14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Re, wherein
Rc at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20- Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, - CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; Rd at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -NO2, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, -CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, Ci-10-alkyl, C2-io-alkenyl,
C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Re at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -NO2, -OH, Ci-10-alkoxy, -O-CH2CH2O- Ci-10-alkyl, -O-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, - CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-10- cycloalkyl, Cs-io-cycloalkenyl and monovalent 3 to 14 membered aliphatic heterocyclic residue, wherein R3 and R4 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, -io-cycloalkyl, Cs-io-cyclo- alkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue,
G1 and G2 are independently from each other -i4-arylene optionally substituted with 1 to 6 substituents Ra or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Ra, wherein
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR8, -S-Ci-3o-alkyl, -NH2, -NHR8, -NR8R9, -NH-COR8, -COOH, -COOR8, -CONH2, -CONHR8, -CONR8R9, -CO-H, -COR8, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rf, -io-cycloalkyl optionally substituted with 1 to 6 substituents Rs, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rs and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rs, wherein
R8 and R9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, -io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Rf at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10 -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10 -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R10 and R11 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, Ce-14-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, or
G1 and G2 are independently from each other
Figure imgf000007_0001
wherein
R5 and R6 are independently from each other H or Ci
is C6-24-arylene optionally substituted with 1 to 6 substituents Rb or bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Rb, wherein
Rb at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR12, -S-Ci-3o-alkyl, -NH2, -NHR12, -NR12R13, -NH-COR12, -COOH, -COOR12, -CONH2, -CONHR 2, -CONR 2R13, -CO-H, -COR12, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rh, C3-io-cyclo- alkyl optionally substituted with 1 to 6 substituents R', Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents R' and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R', wherein
R12 and R13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Rh at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-e-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR14, -CONR R15, -CO-H, -COR14, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
R' at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -N02, -OH , Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -N H2, -N H R14, -N R14R15, -N H-COR14, -COOH , -COOR14, -CON H2, -CON H R 4, -CON R R15, -CO-H , -COR14, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R14 and R15 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, or
L is
Figure imgf000008_0001
wherein
R16 and R17 are independently from each other H , Ci-30-alkyl, -CN or halogen,
q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10Ό00.
Preferably, the semiconducting material of the present invention is a polymer consisting essentially of a unit of formula
Figure imgf000009_0001
wherein R1 and R2 are independently from each other H , Ci-30-alkyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rc, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rd, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rd, monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rd, C6-i4-aryl optionally substituted with 1 to 6 substituents Re or monovalent 5 to14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Re, wherein
Rc at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -N02, -OH , Ci-10-alkoxy, -0-CH2CH20- Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -N H2, -N H R3, -N R3R4, -N H-COR3, -COOH , -COOR3, - CON H2, -CON H R3, -CON R3R4, -CO-H , -COR3, C3-io-cycloalkyl, monovalent 3 to 14 mem- bered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Rd at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -NO2, -OH , Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -N H2, -N H R3, -N R3R4, -N H-COR3, -COOH , -COOR3, -CON H2, -CON H R3, -CON R3R4, -CO-H , -COR3, Ci-10-alkyl, C2-io-alkenyl,
C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Re at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -NO2, -OH , Ci-10-alkoxy, -O-CH2CH2O- Ci-10-alkyl, -O-COR3, -S-Ci-10-alkyl, -N H2, -N H R3, -N R3R4, -N H-COR3, -COOH , -COOR3, - CON H2, -CON H R3, -CON R3R4, -CO-H , -COR3, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-10- cycloalkyl, Cs-io-cycloalkenyl and monovalent 3 to 14 membered aliphatic heterocyclic residue, wherein R3 and R4 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cyclo- alkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue,
G1 and G2 are independently from each other C6-i4-arylene optionally substituted with 1 to 6 substituents Ra or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Ra, wherein
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR8, -S-Ci-3o-alkyl, -NH2, -NHR8, -NR8R9, -NH-COR8, -COOH, -COOR8, -CONH2, -CONHR8, -CONR8R9, -CO-H, -COR8, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rf, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rs, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rs and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rs, wherein
R8 and R9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, Rf at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11 , -NH-COR10, -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11 , -CO-H, -COR10, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monova- lent 5 to 14 membered aromatic heterocyclic residue;
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11 , -NH-COR10, -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11 , -CO-H, -COR10, Ci-10-alkyl,
C2-io-alkenyl, C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R10 and R11 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic hetero- cyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, or
G1 and G2 are independently from each other
Figure imgf000011_0001
wherein
R5 and R6 are independently from each other H or Ci-30-alkyl,
L is C6-24-arylene optionally substituted with 1 to 6 substituents Rb or bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Rb, wherein
Rb at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR12, -S-Ci-3o-alkyl, -NH2, -NHR12, -NR12R13, -NH-COR12,
-COOH, -COOR12, -CONH2, -CONHR 2, -CONR 2R13, -CO-H, -COR12, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rh, C3-io-cyclo- alkyl optionally substituted with 1 to 6 substituents R', Cs-io-cycloalkenyl optionally substi- tuted with 1 to 6 substituents R' and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R', wherein
R12 and R13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Rh at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR14, -CONR R15, -CO-H, -COR14, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; R' at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR14R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR 4, -CONR R15, -CO-H, -COR14, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R14 and R15 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Figure imgf000012_0001
wherein
R16 and R17 are independently from each other H, Ci-30-alkyl, -CN or halogen,
q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10Ό00.
The term "consisting essentially of" means that at least 80% by weight. Preferably at least 90% by weight, of the polymer consists of a unit of formula (1 ) based on the weight of the polymer.
More preferably, the semiconducting material of the present invention is a polymer of formula
Figure imgf000013_0001
wherein R1 and R2 are independently from each other H , Ci-30-alkyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rc, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rd, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rd, monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rd, C6-i4-aryl optionally substituted with 1 to 6 substituents Re or monovalent 5 to14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Re, wherein
Rc at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -N02, -OH , Ci-10-alkoxy, -0-CH2CH20- Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -N H2, -N H R3, -N R3R4, -N H-COR3, -COOH , -COOR3, - CON H2, -CON H R3, -CON R3R4, -CO-H , -COR3, C3-io-cycloalkyl, monovalent 3 to 14 mem- bered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Rd at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -NO2, -OH , Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -N H2, -N H R3, -N R3R4, -N H-COR3, -COOH , -COOR3, -CON H2, -CON H R3, -CON R3R4, -CO-H , -COR3, Ci-10-alkyl, C2-io-alkenyl,
C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Re at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -NO2, -OH , Ci-10-alkoxy, -O-CH2CH2O- Ci-10-alkyl, -O-COR3, -S-Ci-10-alkyl, -N H2, -N H R3, -N R3R4, -N H-COR3, -COOH , -COOR3, - CON H2, -CON H R3, -CON R3R4, -CO-H , -COR3, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-10- cycloalkyl, Cs-io-cycloalkenyl and monovalent 3 to 14 membered aliphatic heterocyclic residue, wherein R3 and R4 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cyclo- alkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue,
G1 and G2 are independently from each other -i4-arylene optionally substituted with 1 to 6 substituents Ra or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Ra, wherein
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR8, -S-Ci-3o-alkyl, -NH2, -NHR8, -NR8R9, -NH-COR8, -COOH, -COOR8, -CONH2, -CONHR8, -CONR8R9, -CO-H, -COR8, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rf, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rs, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rs and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rs, wherein
R8 and R9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, Rf at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10, -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monova- lent 5 to 14 membered aromatic heterocyclic residue;
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10, -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, Ci-10-alkyl,
C2-io-alkenyl, C2-io-alkynyl, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R10 and R11 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic hetero- cyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, or
G1 and G2 are independently from each other
Figure imgf000015_0001
wherein
R5 and R6 are independently from each other H or Ci-30-alkyl,
L is C6-24-arylene optionally substituted with 1 to 6 substituents Rb or bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Rb, wherein
Rb at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR12, -S-Ci-3o-alkyl, -NH2, -NHR12, -NR12R13, -NH-COR12,
-COOH, -COOR12, -CONH2, -CONHR 2, -CONR 2R13, -CO-H, -COR12, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rh, C3-io-cyclo- alkyl optionally substituted with 1 to 6 substituents R', Cs-io-cycloalkenyl optionally substi- tuted with 1 to 6 substituents R' and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R', wherein
R12 and R13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Rh at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR14, -CONR R15, -CO-H, -COR14, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; R' at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR14R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR 4, -CONR R15, -CO-H, -COR14, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R14 and R15 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Figure imgf000016_0001
wherein
R16 and R17 are independently from each other H, Ci-30-alkyl, -CN or halogen,
q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10Ό00.
Ci-12-alkyl, Ci-16-alkyl, C6-2o-alkyl and Ci-30-alkyl can be branched or unbranched. Examples of Ci-12-alkyl are Ci-10-alkyl and n-undecyl and n-dodecyl. Examples of Ci-16-alkyl are Ci-i2-alkyl and n-tridecyl, n-tetradecyl, n-pentadecyl and n-hexadecyl. Examples of Ci-30-alkyl are
Ci-io-alkyl, and n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20), n-docosyl (C22), n-tetracosyl (C24), n-hexacosyl (C26) , n-octacosyl (C2s) and n-triacontyl (C30). Examples of C6-2o-alkyl are n-hexyl, n-heptyl, n-octyl, n-(2-ethyl)hexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20) C2-io-alkenyl and C2-3o-alkenyl can be branched or unbranched. Examples of C2-io-alkenyl are vinyl, propenyl, c/s-2-butenyl, frans-2-butenyl, 3-butenyl, c/s-2-pentenyl, frans-2-pentenyl, c/s-3-pentenyl, frans-3-pentenyl, 4-pentenyl, 2-methyl-3-butenyl, hexenyl, heptenyl, octenyl, nonenyl and docenyl. Examples of C2-3o-alkenyl are C2-io-alkenyl, and linoleyl (ds), linolenyl (Cis), oleyl (Cis), arachidonyl (C20), and erucyl (C22).
C2-io-alkynyl and C2-3o-alkynyl can be branched or unbranched. Examples of C2-io-alkynyl are ethynyl, 2-propynyl, 2-butynyl, 3-butynyl, pentynyl, hexynyl, heptynyl, octynyl, nonynyl and de- cynyl. Examples of C2-3o-alkynyl are C2-io-alkynyl, and undecynyl, dodecynyl, undecynyl, dode- cynyl, tridecynyl, tetradecynyl, pentadecynyl, hexadecynyl, heptadecynyl, octadecynyl, nonade- cynyl and icosynyl (C20).
Examples of C3-io-cycloalkyl are preferably monocyclic C3-io-cycloalkyls such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl, but include also polycyclic C3-io-cycloalkyls such as decalinyl, norbornyl and adamantyl.
Examples of Cs-io-cycloalkenyl are preferably monocyclic Cs-io-cycloalkenyls such as cyclopen- tenyl, cyclohexenyl, cyclohexadienyl and cycloheptatrienyl, but include also polycyclic
Cs-io-cycloalkenyls. Examples of monovalent 3 to 14 membered aliphatic heterocyclic residues are monocyclic monovalent 3 to 8 membered aliphatic cyclic residues and polycyclic, for example bicyclic monovalent 7 to 12 membered aliphatic heterocyclic residues.
Examples of monocyclic monovalent 3 to 8 membered aliphatic heterocyclic residues are mon- ocyclic monovalent 5 membered aliphatic heterocyclic residues containing one heteroatom such as pyrrolidinyl, 1 -pyrrolinyl, 2-pyrrolinyl, 3-pyrrolinyl, tetrahydrofuryl, 2,3-dihydrofuryl, tetrahy- drothiophenyl and 2,3-dihydrothiophenyl, monocyclic monovalent 5 membered aliphatic heterocyclic residues containing two heteroatoms such as imidazolidinyl, imidazolinyl, pyrazolidinyl, pyrazolinyl, oxazolidinyl, oxazolinyl, isoxazolidinyl, isoxazolinyl, thiazolidinyl, thiazolinyl, isothia- zolidinyl and isothiazolinyl, monocyclic monovalent 5 membered aliphatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazolyl, 1 ,2,4-triazolyl and 1 ,4,2-dithiazolyl, monocyclic monovalent 6 membered aliphatic heterocyclic residues containing one heteroatom such as piperidyl, piperidino, tetrahydropyranyl, pyranyl, thianyl and thiopyranyl, monocyclic monovalent 6 membered aliphatic heterocyclic residues containing two heteroatoms such as piperaz- inyl, morpholinyl and morpholino and thiazinyl, monocyclic monovalent 7 membered aliphatic heterocyclic residues containing one hereoatom such as azepanyl, azepinyl, oxepanyl, thi- epanyl, thiapanyl, thiepinyl, and monocyclic monovalent 7 membered aliphatic heterocyclic residues containing two hereoatom such as 1 ,2-diazepinyl and 1 ,3-thiazepinyl.
An example of a bicyclic monovalent 7-12 membered aliphatic heterocyclic residue is decahy- dronaphthyl.
C6-i4-aryl can be monocyclic or polycyclic. Examples of C6-i4-aryl are monocyclic C6-aryl such as phenyl, bicyclic Cg-io-aryl such as 1 -naphthyl, 2-naphthyl, indenyl, indanyl and tetrahy- dronaphthyl, and tricyclic Ci2-i4-aryl such as anthryl, phenanthryl, fluorenyl and s-indacenyl.
The monovalent 5 to 14 membered aromatic heterocyclic residues can be monocyclic monovalent 5 to 8 membered aromatic heterocyclic residues, or polycyclic, for example bicyclic mono- valent 7 to 12 membered, tricyclic monovalent 9 to 14 membered aromatic heterocyclic residue, or tetracyclic monovalent 9 to 14 membered aromatic heterocyclic residues.
Examples of monocyclic monovalent 5 to 8 membered aromatic heterocyclic residues are mon- ocyclic monovalent 5 membered aromatic heterocyclic residues containing one heteroatom such as pyrrolyl, furyl and thiophenyl, monocyclic monovalent 5 membered aromatic heterocyclic residues containing two heteroatoms such as imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thia- zolyl, isothiazolyl, monocyclic monovalent 5 membered aromatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazolyl, 1 ,2,4-triazolyl and oxadiazolyl, monocyclic mono- valent 5 membered aromatic heterocyclic residues containing four heteroatoms such as tetra- zolyl, monocyclic monovalent 6 membered aromatic heterocyclic residues containing one heteroatom such as pyridyl, monocyclic monovalent 6 membered aromatic heterocyclic residues containing two heteroatoms such as pyrazinyl, pyrimidinyl and pyridazinyl, monocyclic monovalent 6 membered aromatic heterocyclic residues containing three heteroatoms such as
1 ,2,3-triazinyl, 1 ,2,4-triazinyl and 1 ,3,5-triazinyl, monocyclic monovalent 7 membered aromatic heterocyclic residues containing one heteroatom such as azepinyl, and monocyclic monovalent 7 membered aromatic heterocyclic residues containing two heteroatoms such as 1 ,2-diazepinyl,
Examples of bicyclic monovalent 7 to 12 membered aromatic heterocyclic residues are bicyclic monovalent 8 membered aromatic heterocyclic residues containing two heteroatoms such as thieno[3,2-b]thiophenyl, bicyclic 9 membered aromatic heterocyclic residues containing one heteroatom such as indolyl, isoindolyl, indolizinyl, indolinyl, benzofuryl, isobenzofuryl, ben- zothiophenyl and isobenzothiophenyl, bicyclic monovalent 9 membered aromatic heterocyclic residues containing two heteroatoms such as indazolyl, benzimidazolyl, benzimidazolinyl, ben- zoxazolyl, benzisooxazolyl, benzthiazolyl, benzisothiazolyl, furopyridyl and thienopyridyl, bicyclic monovalent 9 membered aromatic heterocyclic residues containing three heteroatoms such as benzotriazolyl, benzoxadiazolyl, oxazolopyridyl, isooxazolopyridyl, thiazolopyridyl, isothia- zolopyridyl and imidazopyridyl, bicyclic monovalent 9 membered aromatic heterocyclic residues containing four heteroatoms such as purinyl, bicyclic monovalent 10 membered aromatic heterocyclic residues containing one heteroatom such as quinolyl, isoquinolyl, chromenyl and chromanyl, bicyclic monovalent 10 membered aromatic heterocyclic residues containing two heteroatoms such as quinoxalinyl, quinazolinyl, cinnolinyl, phthalazinyl, 1 ,5-naphthyridinyl and 1 ,8-naphthyridinyl, bicyclic monovalent 10 membered aromatic heterocyclic residues containing three heteroatoms such as pyridopyrazinyl, pyridopyrimidinyl and pyridopyridazinyl, and bicyclic monovalent 10 membered aromatic heterocyclic residues containing four heteroatoms such as pteridinyl.
Examples of tricyclic monovalent 9 to 14 membered aromatic heterocyclic residues are dibenzo- furyl, acridinyl, phenoxazinyl, 7H-cyclopenta[1 ,2-b:3,4-b']dithiophenyl and 4H-cyclopenta- [2,1 -b:3,4-b']dithiophenyl. An example of a tricyclic monovalent 9 to 14 membered aromatic heterocyclic residue containing three heteroatoms is dithienothiophenyl of formula
Figure imgf000019_0001
An example of a tetracyclic monovalent 9 to 14 membered aromatic heterocyclic residue containing four heteroatoms is trithienothiophenyl of formula
Figure imgf000019_0002
Examples of halogen are -F, -CI, -Br and -I.
Examples of Ci-10-alkoxy are methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, fert-butoxy, n-pentoxy, neopentoxy, isopentoxy, hexoxy, n-heptoxy, n-octoxy, n-nonoxy and n-decoxy. Examples of Ci-30-alkoxy are Ci-10-alkoxy, and n-undecoxy,
n-dodecoxy, n-undecoxy, n-dodecoxy, n-tridecoxy, n-tetradecoxy, n-pentadecoxy, n-hexa- decoxy, n-heptadecoxy, n-octadecoxy, n-nonadecoxy and n-icosoxy (C20), n-docosoxy (C22), n-tetracosoxy (C24), n-hexacosoxy (C26), n-octacosoxy (C28) and n-triacontoxy (C30).
Examples of C2-6-alkylene are ethylene, butylene, pentylene, hexylene and 2-methylpentylene. Examples of C6-i4-arylene are monocyclic C6-arylene such as phenylene, bicyclic Cg-io-arylene such as naphthylene, for example
Figure imgf000020_0001
indenylene, for example
Figure imgf000020_0002
*
indanylene, for example
Figure imgf000020_0003
*
and tetrahydronaphthylene, for example
Figure imgf000020_0004
*
and tricyclic Ci2-i4-arylene such as anthrylene, for example
Figure imgf000020_0005
phenanthrylene, for example
Figure imgf000021_0001
fluorenylene, for example
Figure imgf000021_0002
and
s-indacenylene, for example
Figure imgf000021_0003
Examples of C6-24-arylene are C6-i4-arylene and
Figure imgf000021_0004
pyrenylene, for example
Figure imgf000021_0005
* tetracenylene, for example
Figure imgf000022_0001
Figure imgf000022_0002
Figure imgf000022_0003
pentacenylene, for example
Figure imgf000022_0004
*
coronenylene, for example
Figure imgf000022_0005
*
and tetraphenylenylene, for example
Figure imgf000023_0001
The bivalent 5 to 14 membered aromatic heterocyclic residues can be monocyclic bivalent 5 to 8 membered aromatic heterocyclic residues, or polycyclic, for example bicyclic bivalent 7 to 14 membered, tricyclic bivalent 9 to 14 membered aromatic heterocyclic residues, or tetracyclic bivalent 9 to 14 membered aromatic heterocyclic residues.
Examples of monocyclic bivalent 5 to 8 membered aromatic heterocyclic residues are monocyclic bivalent 5 membered aromatic heterocyclic residues containing one heteroatom such as pyr- rolylene, furylene and thiophenylene, monocyclic bivalent 5 membered aromatic heterocyclic residues containing two heteroatoms such as imidazolylene, pyrazolylene, oxazolylene, isoxa- zolylene, thiazolylene, isothiazolylene, monocyclic bivalent 5 membered aromatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazolylene, 1 ,2,4-triazolylene and oxadia- zolylene, monocyclic bivalent 5 membered aromatic heterocyclic residues containing four heteroatoms such as tetrazolylene, monocyclic bivalent 6 membered aromatic heterocyclic residues containing one heteroatom such as pyridylene, monocyclic bivalent 6 membered aromatic heterocyclic residues containing two heteroatoms such as pyrazinylene, pyrimidinylene and pyridazinylene, monocyclic bivalent 6 membered aromatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazinylene, 1 ,2,4-triazinylene and 1 ,3,5-triazinylene, monocyclic bivalent 7 membered aromatic heterocyclic residues containing one heteroatom such as azepinylene, and monocyclic bivalent 7 membered aromatic heterocyclic residues containing two heteroatoms such as 1 ,2-diazepinylene.
Examples of bicyclic bivalent 7 to 14 membered aromatic heterocyclic residues are
bicyclic bivalent 8 membered aromatic heterocyclic residues containing two heteroatoms such as thienothiophenylene, for example
Figure imgf000023_0002
bicyclic bivalent 8 membered aromatic heterocyclic residues containing three heteroatoms such as as thienothiazolylene, for example
Figure imgf000024_0001
bicyclic bivalent 8 membered aromatic heterocyclic residues containing four heteroatoms such as thiazothiazolylene, for example
Figure imgf000024_0002
bicyclic bivalent 9 membered aromatic heterocyclic residues containing one heteroatom such as indolylene, isoindolylene, indolizinylene, indolinylene, isoindolinylene, for example
Figure imgf000024_0003
benzofurylene, isobenzofurylene, benzothiophenylene and isobenzothiophenylene, bicyclic bivalent 9 membered aromatic heterocyclic residues containing two heteroatoms such as indazolylene, benzimidazolylene, benzimidazolinylene, benzoxazolylene, benzisooxa- zolylene, benzthiazolylene, benzisothiazolylene, furopyridylene and thienopyridylene, bicyclic bivalent 9 membered aromatic heterocyclic residues containing three heteroatoms such as benzotriazolylene, benzoxadiazolylene, oxazolopyridylene, isooxazolopyridylene, thia- zolopyridylene, isothiazolopyridylene, imidazopyridylene, benzothiadiazolylene, for example
Figure imgf000024_0004
and dioxanothiophenylene, for example
Figure imgf000024_0005
bicyclic bivalent 9 membered aromatic heterocyclic residues containing four heteroatoms such as purinylene, bicyclic bivalent 10 membered aromatic heterocyclic residues containing one heteroatom such as quinolylene, isoquinolylene, chromenylene and chromanylene, bicyclic bivalent 10 membered aromatic heterocyclic residues containing two heteroatoms such as quinoxalinylene, for example
Figure imgf000025_0001
quinazolinylene, cinnolinylene, phthalazinylene, 1 ,5-naphthyridinylene and
1 ,8-naphthyridinylene, bicyclic bivalent 10 membered aromatic heterocyclic residues containing three heteroatoms such as pyridopyrazinylene, pyridopyrimidinylene and pyridopyridazinylene, and bicyclic bivalent 10 membered aromatic heterocyclic residues containing four heteroatoms such as pterid- inylene. Examples of tricyclic bivalent 9 to 14 membered aromatic heterocyclic residues containing one heteroatom are dibenzofurylene, acridinylene, dibenzosilacyclopentadienylene, for example
Figure imgf000025_0002
and dibenzopyrrolylene, for example
Figure imgf000025_0003
Examples of a tricyclic bivalent 9 to 14 membered aromatic heterocyclic residues containing two heteroatoms are phenoxazinylene, and the following compounds
Figure imgf000025_0004
Figure imgf000026_0001
Figure imgf000026_0002
Examples of tricyclic bivalent 9 to 14 membered aromatic heterocyclic residue containing three heteroatoms are the following compounds
Figure imgf000026_0003
Examples of tricyclic bivalent 9 to 14 membered aromatic heterocyclic residue containing four- heteroatoms are the following compounds
Figure imgf000026_0004
An example of a tricyclic bivalent 9 to 14 membered aromatic heterocyclic residue containing heteroatoms is the following compound
Figure imgf000026_0005
An example of a tetracyclic bivalent 9 to 14 membered aromatic heterocyclic residue containing four heteroatoms is the following compound
Figure imgf000027_0001
Examples of bivalent 5 to 24 membered aromatic heterocyclic residues are bivalent 5 to 14 membered aromatic heterocyclic residues, and the following compounds
Figure imgf000027_0002
Examples of L are:
Figure imgf000027_0003
Figure imgf000027_0004
Figure imgf000028_0001
Figure imgf000028_0002
Figure imgf000029_0001
Figure imgf000029_0002
In preferred units of formula (1 )
R1 and R2 are independently from each other H, Ci-30-alkyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rc, -io-cycloalkyl optionally substituted with 1 to 6 substituents Rd, Cs-io-cycloalkenyl or -i4-aryl optionally substituted with 1 to 6 substituents Re, wherein Rc at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, -CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Rd at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, -CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, Ci-10-alkyl, C2-io-alkenyl,
C2-io-alkynyl, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Re at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, -CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl and monovalent 3 to 14 membered aliphatic heterocyclic residue, wherein R3 and R4 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl,
Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue,
G1 and G2 are independently from each other -i4-arylene optionally substituted with 1 to 6 substituents Ra or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Ra, wherein
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR8, -S-Ci-3o-alkyl, -NH2, -NHR8, -NR8R9, -NH-COR8, -COOH, -COOR8, -CONH2, -CONHR8, -CONR8R9, -CO-H, -COR8, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rf, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rs, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rs and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rs, wherein
R8 and R9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Rf at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10, -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-e-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10,
-COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R10 and R1 1 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
G1 and G2 are independently from each other
Figure imgf000031_0001
wherein
R5 and R6 are independently from each other H or Ci
L is C6-24-arylene optionally substituted with 1 to 6 substituents Rb or bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Rb, wherein
Rb at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -N02, -OH , Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR12, -S-Ci-3o-alkyl, -N H2, -N H R12, -N R12R13, -N H-COR12, -COOH , -COOR12, -CON H2, -CON H R 2, -CON R 2R13, -CO-H , -COR12, Ci-30-alkyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rh, C3-io-cyclo- alkyl optionally substituted with 1 to 6 substituents R', Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents R' and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R', wherein
R12 and R13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, Rh at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -NO2, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-io-alkyl, -NH2, -NHR14, -NR14R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR 4, -CONR R15, -CO-H, -COR14, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
R' at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR14, -CONR R15, -CO-H, -COR14, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R14 and R15 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Figure imgf000032_0001
wherein
R16 and R17 are independently from each other H, Ci-30-alkyl, -CN or halogen,
q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10Ό00. In more preferred units of formula (1 )
R1 and R2 are independently from each other Ci-30-alkyl optionally substituted with 1 to 6 substituents Rc, preferably Ci -alkyl optionally substituted with 1 to 6 substituents Rc, more preferably Ci-12-alkyl optionally substituted with 1 to 6 substituents Rc, wherein
Rc at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -0-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, -CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R3 and R4 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, -io-cycloalkyl, -io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue,
-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue,
G1 and G2 are independently from each other -i4-arylene optionally substituted with 1 to 6 substituents Ra or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Ra, wherein
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C -alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR8, -S-Ci-3o-alkyl, -NH2, -NHR8, -NR8R9, -NH-COR8, -COOH, -COOR8, -CONH2, -CONHR8, -CONR8R9, -CO-H, -COR8, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rf, -io-cycloalkyl optionally substituted with 1 to 6 substituents Rs, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rs and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rs, wherein
R8 and R9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, -io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, Rf at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR10R11, -NH-COR10 -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
R9 at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10 -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R10 and R11 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-10- cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
G1 and G2 are independently from each other
Figure imgf000034_0001
wherein
R5 and R6 are independently from each other H or Ci-30-alkyl,
L is C6-24-arylene optionally substituted with 1 to 6 substituents Rb or bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Rb, wherein
Rb at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR12, -S-Ci-30-alkyl, -NH2, -NHR12, -NR 2R13, -NH-COR12, -COOH, -COOR12, -CONH2, -CONHR12, -CONR 2R13, -CO-H, -COR12, Ci-30-alkyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rh, C3-io-cyclo- alkyl optionally substituted with 1 to 6 substituents R', Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents R' and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R', wherein
R12 and R13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Rh at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-e-alkylene-0-, halogen, -CN, -NO2, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -0-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR14R15, -NH-COR14 -COOH, -COOR14, -CONH2, -CONHR 4, -CONR R15, -CO-H, -COR14, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
R' at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -0-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR 4R15, -NH-COR14 -COOH, -COOR14, -CONH2, -CONHR14, -CONR R15, -CO-H, -COR14, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R14 and R15 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl,
C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Figure imgf000035_0001
wherein
R16 and R17 are independently from each other H, Ci-30-alkyl, -CN or halogen, q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10Ό00.
In even more preferred units of formula (1 )
R1 and R2 are independently from each other Ci-30-alkyl optionally substituted with 1 to 6 sub- stituents Rc, preferably Ci-16-alkyl optionally substituted with 1 to 6 substituents Rc, more preferably Ci-12-alkyl optionally substituted with 1 to 6 substituents Rc, wherein
Rc at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, -CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R3 and R4 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, C5-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue,
G1 and G2 are independently from each other bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Ra, wherein
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR8, -S-Ci-3o-alkyl, -NH2, -NHR8, -NR8R9, -NH-COR8, -COOH, -COOR8, -CONH2, -CONHR8, -CONR8R9, -CO-H, -COR8, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkenyl optionally substituted with 1 to 6 sub- stituents Rf, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rf, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rs, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rs and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rs, wherein
R8 and R9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cyclo- alkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, Rf at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR10R11, -NH-COR10, -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monova- lent 5 to 14 membered aromatic heterocyclic residue; at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10, -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, Ci-10-alkyl,
C2-io-alkenyl, C2-io-alkynyl, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R10 and R11 at each occurrence are independently from each other se- lected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl,
-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, or
G1 and G2 are independently from each other
Figure imgf000037_0001
wherein
R5 and R6 are independently from each other H or Ci-30-alkyl, L is bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Rb, wherein
Rb at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR12, -S-Ci-3o-alkyl, -NH2, -NHR12, -NR12R13, -NH-COR12, -COOH, -COOR12, -CONH2, -CONHR 2, -CONR 2R13, -CO-H, -COR12, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rh, C3-io-cyclo- alkyl optionally substituted with 1 to 6 substituents R', Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents R' and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R', wherein
R12 and R13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Rh at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR14, -CONR R15, -CO-H, -COR14, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
R' at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR R15, -NH-COR14,
-COOH, -COOR14, -CONH2, -CONHR14, -CONR R15, -CO-H, -COR14, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R14 and R15 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
or
Figure imgf000039_0001
wherein
R16 and R17 are independently from each other H, Ci-30-alkyl, -CN or halogen,
q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10Ό00.
In most preferred units of formula (1 )
R1 and R2 are independently from each other Ci-16-alkyl, more preferably Ci-12-alkyl,
G1 and G2 are independently from each other monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue optionally substituted with 1 to 4 substituents Ra, wherein
Ra at each occurrence are independently from each other Ci-30-alkyl optionally substituted with 1 to 4 substituents Rf, wherein
Rf at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR10R11, -NH-COR10, -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent
5 to 14 membered aromatic heterocyclic residue; L is bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 4 substituents Rb, wherein
Rb at each occurrence are independently from each other Ci-30-alkyl optionally substituted with 1 to 4 substituents Rh, wherein
Rh at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR14R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR 4, -CONR R15, -CO-H, -COR14, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
q and s are independently from each other 1 , 2 or 3, r is 1 or 2, and n is an integer from 5 to 10Ό00.
In even most preferred units of formula (1 )
R1 and R2 are independently from each other Ci-16-alkyl, more preferably Ci-i2-alkyl, G1 and G2 are independently from each other monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue, wherein G1 and G2 are substituted with 1 to 2 substituents Ra, wherein
Ra at each occurrence are independently from each other C6-2o-alkyl,
L is bivalent 5 to 14 membered aromatic heterocyclic residue, wherein L is substituted with 1 to 2 substituents Rb, wherein
Rb at each occurrence are independently from each other C6-2o-alkyl, q and s are both 1 , r is 1 , and n is an integer from 5 to 10Ό00.
Particular preferred units of formula (1 ) are units of formula
Figure imgf000041_0001
wherein R1, R2, Ra, L and n are as defined above.
In particular preferred units of formula (1a)
L is
Figure imgf000041_0002
wherein Rb is as defined above.
Preferably, n is an integer from 5 to 5Ό00, more preferably from 5 to 1 Ό00, even more preferably from 5 to 100, and most preferably from 10 to 100. A particular preferred example of the units of formulae (1 ) and (1a) is the unit of formula
Figure imgf000042_0001
The semiconducting material of the present invention can be a polymer comprising preferably at least 80% by weight, more preferably at least 90% by weight, of a unit of formula (1 ), respectively, (1a) based on the weight of the polymer.
Most preferably, the semiconducting material of the present invention is a polymer consisting essentially of a unit of formula (1 ), respectively, (1a).
The polymer comprising a unit of formula (1 ) can be prepared by treating a compound of formula
Figure imgf000042_0002
wherein R1, R2, G1, G2, q and s are as defined above, and Hal1 is halogen, preferably -Br, with a compound of formula
(3)
Figure imgf000042_0003
wherein L and q are as defined above, and R100, R101 and R102 are independently from each other Ci-io-alkyl, preferably methyl. in the presence of transition metal catalyst 1 .
Transition metal catalyst 1 is preferably a palladium catalyst such tris(dibenzylideneacetone)- dipalladium(O), preferably in combination with a phosphine such as tri-otolylphosphine. The reaction is preferably performed at elevated temperatures such 80 to 200 °C, preferably 90 to 150 °C. The reaction can be performed in an inert organic solvent such as chlorobenzene. The reaction can be stopped by the addition of end cappers such as 2-bromothiophene and 2-thiophene boronic acid. The crude product may be worked up by conventional methods, for example by extracting the crude product with an appropriate solvent, for example with acetone.
The compound of formula (2) can be prepared by treating a compound of formula
Figure imgf000043_0001
wherein R1, R2, G1, G2, q and s are as defined above, with a halogenating agent.
The halogenating agent is preferably /V-bromosuccinimide. The reaction is preferably performed at ambient temperatures such -5 to 50 °C, preferably 0 to 30 °C. The reaction can be performed in an organic solvent such chloroform. The crude product may be worked up by conventional methods, for example by column chromatography.
The compound of formula (4) can be prepared by reacting a compound of formula
Figure imgf000043_0002
wherein R1 and R2 are as defined above, with compounds of formulae
Figure imgf000044_0001
(6) wherein G1, G2, q and s are as defined above, and R200, R201 and R202 are independently from each other Ci-10-alkyl, preferably methyl in the presence of a transition metal catalyst 2.
Transition metal catalyst 2 is preferably a palladium catalyst such tetrakis(triphenylphosphine) palladium(O). The reaction is preferably performed at elevated temperatures such 80 to 200 °C, preferably 90 to 150 °C. The reaction can be performed in an inert organic solvent such as di- methylformamide. The crude product may be worked up by conventional methods, for example by column chromatography. The compound of formula (5) can be prepared by treating a compound of formula
Figure imgf000044_0002
wherein R1 and R2 are as defined above, with a halogenating agent.
The halogenating agent is preferably Br2. The reaction is preferably performed at ambient temperatures such -5 to 30 °C, preferably 0 to 30 °C. The reaction can be performed in an organic solvent such dichloromethane. The crude product may be worked up by conventional methods.
The compound of formula (8) can be prepared according to following reaction scheme:
Figure imgf000045_0001
Figure imgf000045_0002
(12) (11)
The compounds of formulae (2), (4) and (5) are also part of the invention.
Also part of the present invention is an electronic device comprising the polymer comprising a unit of formula (1 ) as semiconducting material. Preferably, the electronic device is an organic field effect transistor (OFET), and in particular a thin film transistor (TFT). Preferably, the elec- tronic device is an organic photovoltaic device (OPV).
Usually, an organic field effect transistor comprises a dielectric layer, a semiconducting layer and a substrate. In addition, on organic field effect transistor usually comprises a gate electrode and source/drain electrodes.
An organic field effect transistor can have various designs.
The most common design of a field-effect transistor is the Bottom-Gate Top-Contact (BGTC) design. Here, the gate is on top of the substrate and at the bottom of the dielectric layer, the semiconducting layer is at the top of the dielectric layer and the source/drain electrodes are on top of the semiconducting layer.
Another design of a field-effect transistor is the Top-Gate Bottom-Contact (TGBC) design. Here, the source/drain electrodes are on top of the substrate and at the bottom of the semiconducting layer, the dielectric layer is on top of the semiconducting layer and the gate electrode is on top of the dielectric layer. The semiconducting layer comprises the semiconducting material of the present invention. The semiconducting layer can have a thickness of 5 to 500 nm, preferably of 10 to 100 nm, more preferably of 20 to 50 nm. The dielectric layer comprises a dielectric material. The dielectric material can be silici- um/silicium dioxide, or, preferably, an organic polymer such as polystyrene (PS), polymethylmethacrylate) (PMMA), poly(4-vinylphenol) (PVP), polyvinyl alcohol) (PVA), anzocyclobutene (BCB), or polyimide (PI). The dielectric layer can have a thickness of 10 to 2000 nm, preferably of 50 to 1000 nm, more preferably of 100 to 800 nm.
The source/drain contacts and the gate contact can be made from any suitable material, for example Au.
The substrate can be any suitable substrate such as glass, or a plastic substrate. Preferably the substrate is a plastic substrate such as polyethersulfone, polycarbonate, polysulfone, polyethylene terephthalate (PET) and polyethylene naphthalate (PEN). More preferably, the plastic substrate is a plastic foil.
The organic field effect transistor can be prepared by methods known in the art.
For example, a top-gate bottom-contact (TGBC) thin film transistors (TFTs) can be prepared as follows: first: the source/drain contacts are placed on the substrate, for example by thermal evaporation of the source/drain material; second: the substrate is coated with the semiconduct- ing layer, for example by spin-coating a solution of the semiconducting material in a suitable solvent and drying the semiconducting layer at elevated temperatures, for example at 80 to 100 °C; third: the semiconducting layer is coated with a solution of the dielectric material in a suitable solvent, for example by spin-coating a solution of the dielectric material and drying the dielectric layer at elevated temperatures, for example at 80 to 100 °C; fourth: the gate contact is placed on top of the dielectric layer, for example by thermal evaporation of the gate material.
Also part of the present invention is the use of the polymer comprising the unit of formula (1 ) as semiconducting material.
Electronic devices comprising the semiconducting materials of the present invention show high charge carrier mobility as well as high stability, in particular towards oxidation by air, under ambient environmental conditions. In addition, the semiconducting materials of the present invention are compatible with liquid processing techniques such as spin coating and thus allow the production of low cost, light weight and flexible electronic devices.
Examples
Example 1
Preparation of polymer P1 essentially consisting of units of formula (1 b) The polymer P1 essentially consisting of units of formula (1 b) is prepared according to the following reaction scheme:
Figure imgf000047_0001
Figure imgf000047_0002
(2a) (1b) Preparation of the compound of formula (1 1a)
Methyl iodide (10.9 g, 76.8 mmol) is added to a solution of 1 ,5-naphthyridine (12) (5 g, 38.4 mmol) in MeOH (30 mL) and the reaction mixture is heated at 40 °C over 3 days under N2. The precipitate is filtered and dried under high vacuum to afford compound 1 1a as yellowish green solid (8.51 g, 81 .1 %). 1H NMR (400 MHz, CDCI3, r.t) δ 9.49 (d, 1 H), 9.38 (dd, 1 H), 9.26 (d, 1 H), 8.98 (dd, 1 H), 4.75 (s, 3H).
Preparation of the compound of formula (10a)
NaOH solution (5.6 g, 140.2 mmol, in 30 mL H20) and K3Fe(CN)6 solution (21 .6 g, 65.5 mmol, in 30 mL H2O) are added concurrently over 30 min to a solution of napthyridine methiodide (1 1a) (8.5 g, 31 .2 mmol) in H2O (80 mL) at -10 °C. The reaction mixture is allowed to warm to RT overnight. Excess NaCI is added and the reaction mixture is then extracted with CHC (150 mL x 3). The combined organic phases are dried over Na2S04, filtered and concentrated in vacuo. The crude product is purified by flash column using MeOH+1 % TEA on silica gel to afford compound 10a as violet solid (3.07 g, 61.4 %). 1H NMR (400 MHz, CD3OD, r.t) δ 12.49 (d, 1 H), 12.00 (d, 1 H), 1 1.91 (d, 1 H), 1 1.59 (dd, 1 H), 10.88 (d, 1 H), 8.79 (s, 3H).
Preparation of the compound of formula (9a)
Mel (3.58 mL, 57.5 mmol) is added to a solution of compound 10a (3.07 g, 19.2 mmol) in toluene (50 mL) and the reaction mixture is allowed to stir at 1 15°C for 2 days. The reaction mixture is filtered and dried in vacuo to afford compound 9a as green solid (4.75 g, 81 .8 %). 1H NMR (400 MHz, CD3OD, r.t) δ 8.95 (d, 1 H), 8.79 (d, 1 H), 8.50 (dd, 1 H), 8.19 (dd, 1 H), 7.34 (d, 1 H), 4.63 (s, 3H), 3.87 (s, 3H).
Preparation of the compound of formula (8a)
NaOH solution (4.39 g, 109.7 mmol, in 15 mL H20) and K3Fe(CN)6 solution (15.51 g,
47.1 mmol, in 50 mL of water ) are added concurrently over 30 min to a solution of methyl- napthyridine methiodide 9a (4.75 g, 15.7 mmol) in H2O (25 mL) at 0 °C. The reaction mixture is allowed to stir at 0 °C for 30 min and is then allowed to warm to RT overnight. Excess NaCI is added followed by extraction with CHCb (100 mL x 3). The combined organic phases are dried over Na2S04 and concentrated in vacuo. Recrystallization in MeOH/Acetone mixture afforded compound 8a as orange brown crystals (1 .52 g, 51 .1 %). 1H NMR (400 MHz, CD3OD, r.t) δ 8.04 (d, 2H), 6.92 (d, 2H), 4.87 (s, 3 H), 3.80 (s, 3H).
Preparation of the compound of formula (5a)
1 ,5-dimethylnapthyridine-dione 8a (1 .35 g, 7.08 mmol), NaHCOs (2.38 g, 28.3 mmol) and bromine (2.83 g, 17.1 mmol) are dissolved in dichloromethane/H20 mixture (1 :1 , 200 mL) at 0 °C and allowed to warm to RT overnight. The reaction mixture is filtered and washed with MeOH. Saturated sodium thiosulfate (aq) is added to the filtrate and the aqueous phase is extracted with dichloromethane (200 mL x 3). The combined organic phases are dried over Na2S04 and concentrated in vacuo. The combined solids are dispersed in methanol, subjected to 3 cycles of sonication, followed by centrifugation and decantation to yield yellow compound 5a (2.18 g, 88.5 %). H NMR (400 MHz, DMSO, r.t) δ 8.36 (s, 2H), 3.72 (s, 6H).
Preparation of the compound of formula (4a)
Pd(PPh3)4 (0.1 1 g, 0.10 mmol) is added to a solution of compound 5a (0.68 g, 1.97 mmol) and compounds 6a (2.45 g, 5.90 mmol) in degassed dimethylformamide (23 ml_). The reaction mixture is heated to 130 °C and stirred overnight. The reaction mixture is allowed to cool to RT, washed with H2O (25 ml_), extracted with CH2CI2 (25 ml. x 3), dried over Na2S04 and concentrated. The residue is purified by flash column (0→ 100% ethyl acetate/hexane) to afford com- pound 4a as red solid (0.42 g, 31 %). 1H NMR (400 MHz, CDCI3, r.t) δ 7.71 (s, 2H), 7.42 (d, 2H), 7.04 (d, 2H), 3.82 (s, 6H), 2.73 (t, 4H), 1 .67 - 1 .48 (m, 35H), 0.87 - 0.85 (m, 1 1 H).
Preparation of the compound of formula (2a)
/V-bromosuccinimide (0.17 g, 0.97 mmol) is added to a solution of compound 4a (0.32 g, 0.46 mmol) in CHCI3 (32 ml.) at 0 °C. The temperature of the reaction mixture is allowed to slowly rise to RT and the reaction mixture is stirred overnight. The reaction mixture is quenched with H2O (50 ml_), extracted with CHCI3 (50 ml. x 3), washed with brine, dried over Na?S04 and concentrated. Crude compound 2a is purified by flash column (0→ 50% ethyl acetate/hexane) to afford compound 2a as red solid (0.46 g, 88%). 1H NMR (400 MHz, CDCI3, r.t) δ 7.68 (s, 2H), 6.98 (s, 2H), 3.80 (s, 6H), 2.69 (t, 4H), 1 .68 - 1 .56 (m, 35H), 0.88 - 0.84 (m, 1 1 H).
Preparation of polymer P1 essentially consisting of units of formula (1 b)
Compound 2a (100 mg, 0.12 mmol), compound 3a (1 12 mg, 0.12 mmol), Pd2dba3 (5.4 mg, 0.006 mmol) and P(o-tolyl)3 (3.6 mg, 0.01 mmol) are added to a Schlenk tube and degassed 3 times with nitrogen. Chlorobenzene (3 ml.) is then added and the reaction mixture is heated under N2 at 130 °C. After 2 days, 1 drop of 2-bromothiophene is added and the reaction mixture is allowed to stir for 1 h. 1 drop of 2-(tributylstannyl)thiophene is added and the reaction mixture is allowed to stir at 130 °C overnight. The reaction mixture is poured slowly into 500 ml. of MeOH. The mixture is stirred for 2 h. The precipitate obtained is filtered and subjected to Sox- hlet extraction with acetone overnight. The filtrate is dried under vacuo, dissolved in minimum amount of hot chlorobenzene and precipitated again by pouring it into beaker with methanol. The mixture is stirred for 1 h, filtered and the filtrate is dried under vacuum overnight to afforded polymer P1 as red solid (36 mg, 23 %). 1H NMR (400 MHz, DCE, r.t) δ 7.72 (brs, 2 H), 7.22 - 7.12 (m, 4H), 3.83 (brs, 6 H), 2.80 (brs, 4H), 1.79 - 0.85 (m, 1 12H). Mn: 1 .24 x 104, PDI: 2.53. Example 2
Preparation of top-gate bottom-contact transistors (TGBC) containing the polymer P1 , essentially consisting of the units of formula 1 b, as semiconducting material A top-gate bottom-contact (TGBC) thin film transistor (TFT) is fabricated on glass (PGO glass used as received). Au source-drain contacts (30 nm-thick) are thermally-evaporated. The substrate is then coated with the semiconductor layer (thickness: 40 to 50 nm) by spin-coating (1000 rpm) a solution of polymer P1 (prepared as described in example 1 ) in dichloromethane (concentration ~ 10 mg/mL), and drying the film at 90 °C for 30 seconds. A 4 weight% polysty- rene solution in isopropyl acetate is spin-coated (3600 rpm) and the dielectric film formed is dried at 90 °C for 30 seconds to yield a dielectric layer (thickness: 500 to 600 nm). The device structure is completed by vapor deposition of patterned Au gate contacts (-30 nm thick) through a shadow mask. Channel lengths and widths are 50 μηη and 0.5 mm, respectively, to afford W/L = 10.
The top-gate, bottom-contact (TGBC) thin film transistors of example 2 show the following mobility: 4 x 10-3 cm2V-1s-1.

Claims

Claims
1 . A polymer comprising a unit of formula
Figure imgf000051_0001
wherein
R1 and R2 are independently from each other H , Ci-30-alkyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rc, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rd, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rd, monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rd, C6-i4-aryl optionally substituted with 1 to 6 substituents Re or monovalent 5 to14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Re, wherein Rc at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -N02, -OH , Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -N H2, -N H R3, -N R3R4, -N H-COR3, -COOH , -COOR3, -CON H2, -CON H R3, -CON R3R4, -CO-H , -COR3, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Rd at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -NO2, -OH , Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -N H2, -N H R3, -N R3R4, -N H-COR3, -COOH , -COOR3, -CON H2, -CON H R3, -CON R3R4, -CO-H , -COR3, Ci-10-alkyl, C2-io-alkenyl,
C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Re at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -NO2, -OH , Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -N H2, -N H R3, -N R3R4, -N H-COR3, -COOH , -COOR3, -CON H2, -CON H R3, -CON R3R4, -CO-H , -COR3, Ci-10-alkyl, C2-io-alkenyl,
C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl and monovalent 3 to 14 membered aliphatic heterocyclic residue, wherein R3 and R4 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cyclo- alkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue,
G1 and G2 are independently from each other -i4-arylene optionally substituted with 1 to 6 substituents Ra or bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Ra, wherein
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR8, -S-Ci-3o-alkyl, -NH2, -NHR8, -NR8R9, -NH-COR8, -COOH, -COOR8, -CONH2, -CONHR8, -CONR8R9, -CO-H, -COR8, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rf, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rs, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rs and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents Rs, wherein
R8 and R9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Rf at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10, -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10, -COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R10 and R11 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, or
G1 and G2 are independently from each other
Figure imgf000053_0001
wherein
R5 and R6 are independently from each other H or Ci
is C6-24-arylene optionally substituted with 1 to 6 substituents Rb or bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Rb, wherein
Rb at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR12, -S-Ci-3o-alkyl, -NH2, -NHR12, -NR12R13, -NH-COR12, -COOH, -COOR12, -CONH2, -CONHR 2, -CONR 2R13, -CO-H, -COR12, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rh, C3-io-cyclo- alkyl optionally substituted with 1 to 6 substituents R', Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents R' and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R', wherein
R12 and R13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Rh at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-e-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR14, -CONR R15, -CO-H, -COR14, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
R' at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR14R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR 4, -CONR R15, -CO-H, -COR14, Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, -i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R14 and R15 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, or
L is
Figure imgf000054_0001
wherein
R16 and R17 are independently from each other H, Ci-30-alkyl, -CN or halogen, q and s are independently from each other 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10Ό00.
2. The polymer of claim 1 , wherein
R1 and R2 are independently from each other H, Ci-30-alkyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rc, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rc, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rd, Cs-io-cycloalkenyl or C6-i4-aryl optionally substituted with 1 to 6 sub- stituents Re, wherein
Rc at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -0-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, -CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Rd at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, -CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, Ci-10-alkyl, C2-io-alkenyl,
C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Re at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -0-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, -CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, Ci-10-alkyl, C2-io-alkenyl,
C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl and monovalent 3 to 14 membered aliphatic heterocyclic residue, wherein R3 and R4 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue.
3. The polymer of claim 1 , wherein
R1 and R2 are independently from each other Ci-30-alkyl optionally substituted with 1 to 6 substituents Rc, wherein
Rc at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -0-COR3, -S-Ci-10-alkyl, -NH2, -NHR3, -NR3R4, -NH-COR3, -COOH, -COOR3, -CONH2, -CONHR3, -CONR3R4, -CO-H, -COR3, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R3 and R4 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, C5-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue.
4. The polymer of claim 1 , wherein
R1 and R2 are independently from each other Ci-16-alkyl, more preferably Ci-12-alkyl.
5. The polymer of any of claims 1 to 4, wherein
G1 and G2 are independently from each other bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Ra, wherein
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR8, -S-Ci-3o-alkyl, -NH2, -NHR8, -NR8R9, -NH-COR8, -COOH, -COOR8, -CONH2, -CONHR8, -CONR8R9, -CO-H, -COR8, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rf, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rf, C3-io-cycloalkyl optionally substituted with 1 to 6 substituents Rs, Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents Rs and monovalent 3 to 14 membered aliphatic heterocyclic resi- due optionally substituted with 1 to 6 substituents Rs, wherein
R8 and R9 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cyclo- alkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Rf at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10,
-COOH, -COOR10, -CONH2, -CONHR10, -CONR 0R11, -CO-H, -COR10, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue;
Ra at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -NH2, -NHR10, -NR 0R11, -NH-COR10, -COOH , -COOR10, -CON H2, -CON H R10, -CON R 0R1 1 , -CO-H , -COR10, Ci-io-alkyl, C2-io-alkenyl, C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R10 and R1 1 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
G1 and G2 are independently from each other
Figure imgf000057_0001
wherein
R5 and R6 are independently from each other H or Ci-30-alkyl.
6. The polymer of any of claims 1 to 4, wherein
G1 and G2 are independently from each other monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue optionally substituted with 1 to 4 substituents Ra, wherein
Ra at each occurrence are independently from each other Ci-30-alkyl optionally substituted with 1 to 4 substituents Rf, wherein
Rf at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN , -NO2, -OH , Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR10, -S-Ci-10-alkyl, -N H2, -N H R10, -N R10R1 1 , -N H-COR10, -COOH , -COOR10, -CON H2, -CON H R10, -CON R 0R1 1 , -CO-H , -COR10, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue.
7. The polymer of any of claims 1 to 4, wherein
G1 and G2 are independently from each other monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue, wherein G1 and G2 are substituted with 1 to 2 substituents Ra, wherein
Ra at each occurrence are independently from each other C6-2o-alkyl.
8. The polymer of any of claims 1 to 7, wherein
L is bivalent 5 to 24 membered aromatic heterocyclic residue optionally substituted with 1 to 6 substituents Rb, wherein
Rb at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-30-alkoxy,
-0-CH2CH20-Ci-3o-alkyl, -O-COR12, -S-Ci-3o-alkyl, -NH2, -NHR 2, -NR12R13, -NH-COR12, -COOH, -COOR12, -CONH2, -CONHR 2, -CONR 2R13, -CO-H, -COR12, Ci-so-alkyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkenyl optionally substituted with 1 to 6 substituents Rh, C2-3o-alkynyl optionally substituted with 1 to 6 substituents Rh, C3-io-cyclo- alkyl optionally substituted with 1 to 6 substituents R', Cs-io-cycloalkenyl optionally substituted with 1 to 6 substituents R' and monovalent 3 to 14 membered aliphatic heterocyclic residue optionally substituted with 1 to 6 substituents R', wherein
R12 and R13 at each occurrence are independently from each other selected from the group consisting of Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue, Rh at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR14, -CONR R15, -CO-H, -COR14, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monova- lent 5 to 14 membered aromatic heterocyclic residue;
R' at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy, -0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR14, -CONR R15, -CO-H, -COR14, Ci-10-alkyl,
C2-io-alkenyl, C2-io-alkynyl, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue; wherein R14 and R15 at each occurrence are independently from each other selected from the group consisting of Ci-10-alkyl, C2-io-alkenyl, C2-io-alkynyl,
C3-io-cycloalkyl, Cs-io-cycloalkenyl, monovalent 3 to 14 membered aliphatic hetero- cyclic residue, C6-i4-aryl and monovalent 5 to14 membered aromatic heterocyclic residue,
Figure imgf000059_0001
wherein
R16 and R17 are independently from each other H, Ci-30-alkyl, -CN or halogen.
9. A polymer of any of claims 1 to 7, wherein
L is bivalent 5 to 14 membered aromatic heterocyclic residue optionally substituted with 1 to 4 substituents Rb, wherein
Rb at each occurrence are independently from each other Ci-30-alkyl optionally substituted with 1 to 4 substituents Rh, wherein
Rh at each occurrence are independently from each other selected from the group consisting of =0, =C(CN)2, -0-C2-6-alkylene-0-, halogen, -CN, -N02, -OH, Ci-10-alkoxy,
-0-CH2CH20-Ci-io-alkyl, -O-COR14, -S-Ci-10-alkyl, -NH2, -NHR14, -NR14R15, -NH-COR14, -COOH, -COOR14, -CONH2, -CONHR 4, -CONR R15, -CO-H, -COR14, C3-io-cycloalkyl, monovalent 3 to 14 membered aliphatic heterocyclic residue, C6-i4-aryl and monovalent 5 to 14 membered aromatic heterocyclic residue.
10. A polymer of any of claims 1 to 7, wherein
L is bivalent 5 to 14 membered aromatic heterocyclic residue, wherein L is substituted with 1 to 2 substituents Rb, wherein
Rb at each occurrence are independently from each other C6-2o-alkyl.
1 1 . A polymer of any of claims 1 to 10, wherein
q and s are independently from each other 1 , 2 or 3,
r is 1 or 2,
and
n is an integer from 5 to 10Ό00.
12. A polymer of claim 1 1 , wherein
q and s are both 1 ,
r is 1 ,
and
n is an integer from 5 to 10Ό00.
13. A polymer of claim 1 , wherein the unit of formula (1 ) is a unit of formula
Figure imgf000060_0001
wherein R1, R2, Ra, L and n are as defined in claim 1 .
14. A polymer of claim 13, wherein L is
Figure imgf000060_0002
wherein Rb is as defined in claim 1 .
15. A polymer of any of claims 1 to 14, wherein n is an integer from 5 to 5Ό00, preferably from 5 to 1 Ό00, more preferably from 5 to 100, and most preferably from 10 to 100.
16. An electronic device comprising the polymer of any of claims 1 to 15.
17. The electronic device of claim 16, wherein the electronic device is an organic field effect transistor (OFET).
18. The electronic device of claim 16, wherein the electronic device is an organic photovoltaic device (OPV).
19. Use of the polymer of any of claims 1 to 15 as semiconducting material.
PCT/EP2012/057438 2011-04-28 2012-04-24 Semiconductor materials based on diketopiperidinopiperidine copolymers WO2012146574A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP12716040.6A EP2702086B1 (en) 2011-04-28 2012-04-24 Semiconductor materials based on diketopiperidinopiperidine copolymers
JP2014506832A JP5777802B2 (en) 2011-04-28 2012-04-24 Semiconductor materials based on diketopiperidinopiperidine copolymers
KR1020137031153A KR101486694B1 (en) 2011-04-28 2012-04-24 Semiconductor materials based on diketopiperidinopiperidine copolymers
CN201280020623.4A CN103492452B (en) 2011-04-28 2012-04-24 Based on diketo piperidines and the semiconductor material of piperidines multipolymer

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161479872P 2011-04-28 2011-04-28
EP11164088.4 2011-04-28
US61/479,872 2011-04-28
EP11164088 2011-04-28

Publications (1)

Publication Number Publication Date
WO2012146574A1 true WO2012146574A1 (en) 2012-11-01

Family

ID=47071619

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/057438 WO2012146574A1 (en) 2011-04-28 2012-04-24 Semiconductor materials based on diketopiperidinopiperidine copolymers

Country Status (6)

Country Link
EP (1) EP2702086B1 (en)
JP (1) JP5777802B2 (en)
KR (1) KR101486694B1 (en)
CN (1) CN103492452B (en)
TW (1) TWI544000B (en)
WO (1) WO2012146574A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013182262A1 (en) * 2012-06-04 2013-12-12 Merck Patent Gmbh Organic semiconductors
JP2015023190A (en) * 2013-07-19 2015-02-02 富士フイルム株式会社 Organic thin film transistor, organic semiconductor thin film, and organic semiconductor material
JP2015023188A (en) * 2013-07-19 2015-02-02 富士フイルム株式会社 Organic thin film transistor, organic semiconductor thin film, and organic semiconductor material

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10079346B2 (en) * 2014-12-19 2018-09-18 Basf Se Heteroaromatic compounds for organic electronics
WO2018169256A2 (en) * 2017-03-16 2018-09-20 서울대학교산학협력단 Polymer, organic solar cell comprising polymer, perovskite solar cell comprising polymer
KR102024826B1 (en) * 2018-02-19 2019-09-24 서울대학교산학협력단 polymer using photo-active layer of organic solar cell and organic solar cell comprising thereof
US11387413B2 (en) 2017-03-16 2022-07-12 Seoul National University R&Db Foundation Polymer, organic solar cell comprising polymer, perovskite solar cell comprising polymer
KR20200055361A (en) 2018-11-13 2020-05-21 삼성전자주식회사 Organic device and image sensor

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050090640A1 (en) * 2003-08-28 2005-04-28 Martin Heeney Mono-, oligo-and polythieno[2,3-b]thiophenes
EP2034537A2 (en) * 2007-09-06 2009-03-11 Xerox Corporation Diketopyrrolopyrrole-based derivatives for thin film transistors
WO2009105042A1 (en) * 2008-02-22 2009-08-27 Nanyang Technological University Thienothiophene derivatives
WO2009123695A1 (en) * 2008-03-31 2009-10-08 Corning Incorporated Fused thiophenes and methods for making and using same
WO2010108873A1 (en) * 2009-03-23 2010-09-30 Basf Se Diketopyrrolopyrrole polymers for use in organic semiconductor devices

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8664339B2 (en) * 2008-11-07 2014-03-04 Polyera Corporation Organic semiconducting polymers
WO2013182262A1 (en) * 2012-06-04 2013-12-12 Merck Patent Gmbh Organic semiconductors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050090640A1 (en) * 2003-08-28 2005-04-28 Martin Heeney Mono-, oligo-and polythieno[2,3-b]thiophenes
EP2034537A2 (en) * 2007-09-06 2009-03-11 Xerox Corporation Diketopyrrolopyrrole-based derivatives for thin film transistors
WO2009105042A1 (en) * 2008-02-22 2009-08-27 Nanyang Technological University Thienothiophene derivatives
WO2009123695A1 (en) * 2008-03-31 2009-10-08 Corning Incorporated Fused thiophenes and methods for making and using same
WO2010108873A1 (en) * 2009-03-23 2010-09-30 Basf Se Diketopyrrolopyrrole polymers for use in organic semiconductor devices

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BAO, Z.; DOBADALAPUR, A.; LOVINGER, A., J. APPL. PHYS. LETT., vol. 69, 1996, pages 4108 - 4110
E. BISAGNI; C. LANDRAS; S. THIROT; C. HUEL., TETRAHEDRON, vol. 52, no. 31, 1996, pages 10427 - 10440
H. IRIKAWA; N. ADACHI, HETEROCYCLES, vol. 53, no. 1, 2000, pages 135 - 142
J. C. BIJLEVELD; A. P. ZOOMBELT; S. G. J. MATHIJSSEN; M. M. WIENK; M. TURBIEZ; D. M. DE LEEUW; R. A. J. JANSSEN, J. AM. CHEM. SOC., vol. 131, 2009, pages 16616 - 16617
L. BÜRGI; M. TURBIEZ; R. PFEIFFER; F. BIENEWALD; H.-J. KIRNER; C. WINNEWISSER, ADV. MATER., vol. 20, 2008, pages 2217 - 2224
N. SAITO; T. YAMAMOTO, MACROMOLECULES, vol. 28, 1995, pages 4260 - 4267
ONG, B. S.; WU,Y.; LIU, P.; GARDNER, S., J. AM. CHEM. SOC., vol. 126, 2004, pages 3378 - 3379
ZHANG, M.; TSAO, H. N.; PISULA, W.; YANG, C.; MISHRA, A. K.; MÜLLEN, K., J. AM. CHEM. SOC., vol. 129, 2007, pages 3472 - 3473
ZOU, Y.; NAJARI, A.; BERROUARD, P.; BEAUPRE, S.; BADROU, R. A.; TAO, Y.; LECLERC, M., J. AM. CHEM. SOC., vol. 132, 2010, pages 5330 - 5331

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013182262A1 (en) * 2012-06-04 2013-12-12 Merck Patent Gmbh Organic semiconductors
JP2015023190A (en) * 2013-07-19 2015-02-02 富士フイルム株式会社 Organic thin film transistor, organic semiconductor thin film, and organic semiconductor material
JP2015023188A (en) * 2013-07-19 2015-02-02 富士フイルム株式会社 Organic thin film transistor, organic semiconductor thin film, and organic semiconductor material

Also Published As

Publication number Publication date
KR20140018349A (en) 2014-02-12
CN103492452B (en) 2016-01-20
EP2702086B1 (en) 2015-03-18
TW201247739A (en) 2012-12-01
KR101486694B1 (en) 2015-01-26
TWI544000B (en) 2016-08-01
JP2014514414A (en) 2014-06-19
CN103492452A (en) 2014-01-01
EP2702086A1 (en) 2014-03-05
JP5777802B2 (en) 2015-09-09

Similar Documents

Publication Publication Date Title
EP2702086B1 (en) Semiconductor materials based on diketopiperidinopiperidine copolymers
JP5693722B2 (en) Semiconductor materials made from crosslinked bithiazole copolymers
TWI534173B (en) Fused random bithiophene-vinylene copolymers
KR101489617B1 (en) Semiconductor materials based on thienothiophene-2,5-dione oligomers and polymers
Li et al. Poly (2, 5-bis (2-octyldodecyl)-3, 6-di (furan-2-yl)-2, 5-dihydro-pyrrolo [3, 4-c] pyrrole-1, 4-dione-co-thieno [3, 2-b] thiophene): a high performance polymer semiconductor for both organic thin film transistors and organic photovoltaics
Kim et al. Benzotriazole-based donor–acceptor type semiconducting polymers with different alkyl side chains for photovoltaic devices
Ashraf et al. Fused ring thiophene-based poly (heteroarylene ethynylene) s for organic solar cells
KR20110118631A (en) Semiconductor materials prepared from dithienylvinylene copolymers
EP2707455A1 (en) Halogenated perylene-based semiconducting materials
KR101486693B1 (en) Semiconductor materials based on dithienopyridone copolymers
Min et al. Low bandgap copolymer of 1, 4-diketopyrrolo [3, 4-c] pyrrole and thieno [3, 2-b] thiophene: Synthesis and applications in polymer solar cells and field-effect transistors
US8436127B2 (en) Semiconductor materials based on diketopiperidinopiperidine copolymers
Deng et al. Synthesis, field-effect and photovoltaic properties of random difluorobenzothiadiazole-isoindigo electron donor-acceptor polymers
US8431680B2 (en) Semiconductor materials based on thienothiophene-2,5-dione oligomers and polymers
US20140273339A1 (en) Semiconductor Polymers
US8394919B2 (en) Semiconductor materials based on dithienopyridone copolymers
US20120289703A1 (en) Halogenated perylene-based semiconducting materials

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12716040

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2012716040

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2014506832

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20137031153

Country of ref document: KR

Kind code of ref document: A